The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J06 | Immune sera and immunoglobulins | |
| 3 | J06B | Immunoglobulins | |
| 4 | J06BB | Specific immunoglobulins | |
| 5 | J06BB04 | Hepatitis B immunoglobulin |
| Active Ingredient | Description | |
|---|---|---|
| Human hepatitis B immunoglobulin |
Human hepatitis B immunoglobulin solution for infusion contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against hepatitis B virus surface antigen (HBs). It is used for the immunoprophylaxis of hepatitis B and the prevention of hepatitis B virus re-infection after liver transplantation for hepatitis B induced liver failure. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| HEPAGAM B Solution for infusion | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| HEPATECT CP Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| HYPERHEP B Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| ZUTECTRA Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
